Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Edward Cooper
Baylor College of Medicine, Department: Neurology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Knopp Biosciences, Inc.
Payment for services (e.g., consulting fees, honoraria, paid authorship)
The investigator recently acquired this SFI. Knopp is a biotech company that develops a drug to treat KCNQ2 encephalopathy. The investigator is an expert in this rare disorder and advises the company and others about the disease and its pathophysiology. This research involves pediatric epilepsy. Although the potential for conflict is indirect, there might be concern that the research could be biased to favor treatment through the future approaches being developed. The research is a retrospective chart review without consent. The committee determined that the SFI may directly and/or significantly affect the research because the investigator is involved in all aspects of the study. The committee further determined there appears to be a FCOI, but it could easily be managed.
KCNQ2/3 channels in neonatal-onset epilepsy and encephalopathy
Proteins called ion channels create the electrical signals in the brain that are the physical basis for activities such as thinking, sensation, and body movement. Ion channel variants can be responsible for several types of epilepsy which begin early after birth and are sometime followed by severe developmental delay. This study will analyze how variation in the ion channel called KCNQ2 cause such symptoms and test new strategies for treating and curing affected individuals, by using molecular biology, and studies of cells in culture and mice.
Filed on March 01, 2018.
Tell us what you know about Edward Cooper's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Edward Cooper filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Edward Cooper | Baylor College of Medicine | Conflict of Interest | Knopp Biosciences, Inc. | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.